Avi Pelossof
CIK 1293460 · GlobalPres, Infectious Disease · last filed 2025-10-28
Avi Pelossof is a GlobalPres, Infectious Disease who has filed 14 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider was granted $120.0K of NEOG on Oct 28, 2025. Current disclosed insider exposure totals $229.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$229.3K
2
14
$0
Filer Profile
MEDFORD, NY 11763
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEOG | Director | 19,386 | $11.83 | $229.3K | $0 | 1 | 2025-10-28 |
| ALERE INC. (ALR) Delisted | GlobalPres, Infectious Disease | 0 | $1.32 | $0 | $0 | 12 | 2017-10-03 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-28 | NEOG | Grant (A) | +19,386 | $120.0K | EDGAR |
| 2017-10-03 | ALERE INC. (ALR) Delisted | Disp (D) | −26,005 | $0 | EDGAR |
| 2017-09-05 | ALERE INC. (ALR) Delisted | Mixed | +4,203 | -$121.9K | EDGAR |
| 2017-02-21 | ALERE INC. (ALR) Delisted | Mixed | +6,071 | -$148.1K | EDGAR |
| 2017-01-04 | ALERE INC. (ALR) Delisted | Mixed | +207 | -$3.1K | EDGAR |
| 2016-09-13 | ALERE INC. (ALR) Delisted | Exer (M) | +6,667 | $0 | EDGAR |
| 2016-02-18 | ALERE INC. (ALR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-02 | ALERE INC. (ALR) Delisted | Mixed | +4,202 | -$128.1K | EDGAR |
| 2015-03-03 | ALERE INC. (ALR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-27 | ALERE INC. (ALR) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.